These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22190207)

  • 41. Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.
    Kane GC; Doyle BJ; Lerman A; Barsness GW; Best PJ; Rihal CS
    J Am Coll Cardiol; 2008 Jan; 51(1):89-90. PubMed ID: 18174044
    [No Abstract]   [Full Text] [Related]  

  • 42. Assessment of urinary N-acetyl-β-glucosaminidase as an early marker of contrast-induced nephropathy.
    Ren L; Ji J; Fang Y; Jiang SH; Lin YM; Bo J; Qian JY; Xu XH; Ding XQ
    J Int Med Res; 2011; 39(2):647-53. PubMed ID: 21672370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. When to test renal function to disclose contrast-induced nephropathy.
    Aguiar-Souto P; Valero-González S
    Am J Cardiol; 2008 Aug; 102(3):371. PubMed ID: 18638608
    [No Abstract]   [Full Text] [Related]  

  • 44. Is renal function-based contrast dosing of radiographic contrast media in patients undergoing percutaneous coronary intervention sufficient to delineate safe limits of contrast dose?
    Kalra N; Fenster P
    J Am Coll Cardiol; 2012 Jan; 59(4):432; author reply 432-3. PubMed ID: 22261170
    [No Abstract]   [Full Text] [Related]  

  • 45. Contrast-induced nephropathy: does it really exist?
    Buckenham TM
    N Z Med J; 2009 Jul; 122(1299):5-6. PubMed ID: 19684640
    [No Abstract]   [Full Text] [Related]  

  • 46. Risk score for contrast induced nephropathy following percutaneous coronary intervention.
    Ghani AA; Tohamy KY
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):240-5. PubMed ID: 19237811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines.
    Thomsen HS; Morcos SK
    Br J Radiol; 2003 Aug; 76(908):513-8. PubMed ID: 12893691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preventing nephropathy induced by contrast medium.
    Hellman RN
    N Engl J Med; 2006 Apr; 354(17):1853-5; author reply 1853-5. PubMed ID: 16642595
    [No Abstract]   [Full Text] [Related]  

  • 49. "CIN" no more: the use of contrast volume to e-GFR ratio to predict and prevent contrast-induced acute kidney injury.
    Yu J; Mehran R
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1201-2. PubMed ID: 22234921
    [No Abstract]   [Full Text] [Related]  

  • 50. Water for contrast-induced nephropathy? A thirst for knowledge.
    Pate GE; Webb JG
    J Invasive Cardiol; 2003 Dec; 15(12):703-5. PubMed ID: 14660822
    [No Abstract]   [Full Text] [Related]  

  • 51. High Dose of Atorvastatin for the Treatment of Contrast-Induced Nephropathy After Carotid Artery Stenting.
    Fu M; Dai W; Ye Y; Lu Q; He W
    Am J Ther; 2017; 24(6):e718-e722. PubMed ID: 26720167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recognizing and reducing the cardiac risk of renal failure.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2008 Sep; 72(3):355-356. PubMed ID: 18729175
    [No Abstract]   [Full Text] [Related]  

  • 54. Contrast alternatives for iodinated contrast allergy and renal dysfunction: options and limitations.
    Nadolski GJ; Stavropoulos SW
    J Vasc Surg; 2013 Feb; 57(2):593-8. PubMed ID: 23246079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute hyperglycemia: is really a new risk marker for contrast-induced nephropathy in patients with acute myocardial infarction without diabetes and normal renal function?
    Raposeiras-Roubín S; Barreiro Pardal C; Ocaranza R; Cid B; González-Juanatey JR
    Am Heart J; 2011 Jul; 162(1):e7; author reply e9. PubMed ID: 21742082
    [No Abstract]   [Full Text] [Related]  

  • 56. A randomized trial of intravenous n-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes.
    Jaffery Z; Verma A; White CJ; Grant AG; Collins TJ; Grise MA; Jenkins JS; McMullan PW; Patel RA; Reilly JP; Thornton SN; Ramee SR
    Catheter Cardiovasc Interv; 2012 May; 79(6):921-6. PubMed ID: 21542122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.
    Marenzi G; Assanelli E; Marana I; Lauri G; Campodonico J; Grazi M; De Metrio M; Galli S; Fabbiocchi F; Montorsi P; Veglia F; Bartorelli AL
    N Engl J Med; 2006 Jun; 354(26):2773-82. PubMed ID: 16807414
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
    Shin DH; Choi DJ; Youn TJ; Yoon CH; Suh JW; Kim KI; Cho YS; Cho GY; Chae IH; Kim CH
    Am J Cardiol; 2011 Jul; 108(2):189-94. PubMed ID: 21545991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
    Juergens CP; Winter JP; Nguyen-Do P; Lo S; French JK; Hallani H; Fernandes C; Jepson N; Leung DY
    Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Re: contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media?
    Downes MO; Nicholson A
    Clin Radiol; 2010 Apr; 65(4):343-4; author reply 344-5. PubMed ID: 20338404
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.